DBH Inhibitors Modulate Immune Response for Autoimmune Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for autoimmune diseases often cause significant adverse effects and irreversible damage, highlighting the need for a safe and effective therapeutic agent.
Innovation Solution
The use of pathway modulators, specifically dopamine β-hydroxylase inhibitors like Nepicastat, Etamicastat, and Zamicastat, to treat autoimmune diseases by immunoregulation, thereby reducing inflammation and disease progression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for autoimmune diseases are used, then disease symptoms can be controlled, but significant adverse effects and irreversible damage occur
Solution Approach 1:
The patent applies parameter changes by modulating the dopamine β-hydroxylase enzyme activity through chemical inhibitors (such as nepicastat, etamicastat, and zamicastat). This changes the biochemical parameters of the immune system, specifically affecting catecholamine synthesis in immune cells, which in turn modulates immune responses. This approach achieves therapeutic efficacy while avoiding the severe adverse effects of traditional immunosuppressants by targeting a specific enzymatic pathway rather than broadly suppressing immunity.
2Stability of the object's composition
If traditional immunosuppressants are used, then autoimmune disease progression is halted, but irreversible damage to the patient occurs
Solution Approach 1:
The patent introduces dopamine β-hydroxylase as an intermediary target. Instead of directly suppressing immune cells or using harsh immunosuppressants, the invention uses DBH inhibitors to modulate the enzymatic conversion of dopamine to norepinephrine in immune cells. This intermediary enzymatic pathway modulation creates a gentler, more controllable effect on immune function, maintaining disease control while significantly improving patient safety and avoiding irreversible damage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These DBH inhibitors effectively ameliorate weight loss, improve disease activity indices, and return colon density to normal, providing a potential therapeutic option for autoimmune diseases with reduced adverse effects.
Implementation Method 1
DBH catalyzes the oxidation of dopamine by oxygen to generate norepinephrine and epinephrine
Data Source
AI summary
A pathway modulator, a pharmaceutical composition having same, use thereof, and a therapeutic method using same. The pathway modulator (comprising one or more of a dopamine β-hydroxylase inhibitor, a receptor agonist and a receptor antagonist) can inhibit development of autoimmune diseases by immunoregulation, thereby providing potential therapeutic drugs for the treatment of autoimmune diseases.